2023
DOI: 10.1016/j.eclinm.2023.101921
|View full text |Cite
|
Sign up to set email alerts
|

Determinants of health-related quality-of-life in adult survivors of childhood cancer: integrating personal and societal values through a health utility approach

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 26 publications
0
2
0
Order By: Relevance
“…Two multinomial logistic regression models analyzed characteristics of global cumulative symptom burden and burden of each symptom. Model 1 included personal risk factors (eg, survivor’s age and diagnosis) 20 , 21 and contextual risk factors (ie, family conflict, neighborhood deprivation, and caregiver anxiety) of greater symptom burden. Model 2 added survivor’s meaning/purpose to the risk factors in model 1.…”
Section: Methodsmentioning
confidence: 99%
“…Two multinomial logistic regression models analyzed characteristics of global cumulative symptom burden and burden of each symptom. Model 1 included personal risk factors (eg, survivor’s age and diagnosis) 20 , 21 and contextual risk factors (ie, family conflict, neighborhood deprivation, and caregiver anxiety) of greater symptom burden. Model 2 added survivor’s meaning/purpose to the risk factors in model 1.…”
Section: Methodsmentioning
confidence: 99%
“…Over the past decade, many national/regional groups and cancer institutions have initiated large prospective cohort studies and registries to characterize the health and psychosocial outcomes of childhood cancer survivors. These chronic consequences of childhood cancer treatment negatively impact the physical and psychosocial wellbeing of pediatric cancer survivors and emphasize cancer survivorship as an unmet need [54,55]. However, it is important to note that these registries reflect the effects of conventional anti-cancer therapies (chemotherapy/radiotherapy) and may not reflect the trajectories of survivorship comorbidities associated with novel anti-cancer therapies, such as immunotherapy.…”
Section: Survivorship and Life After Cancer Therapymentioning
confidence: 99%